Evidence map›Paper›PMID 40464112›Full record

ArticleClinical obesity2025

Estimating the association and timing of occurrence between obesity and related comorbidity outcomes in a real-world setting: A cohort study in the United States.

Firas Dabbous, Jigish Bhavsar, Jayashri Desai, Anthony Fabricatore, Bríain Ó Hartaigh, Wojciech Michalak, Sariya Udayachalerm, Cynthia Saiontz-Martinez, Zhenxiang Zhao, Fatima Cody Stanford

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Firas DabbousData Analytics, Evidera Inc., Wilmington, North Carolina, USA.
Jigish BhavsarNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Jayashri DesaiNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Anthony FabricatoreNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Bríain Ó HartaighNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Wojciech MichalakNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Sariya UdayachalermData Analytics, Evidera Inc., Wilmington, North Carolina, USA.
Cynthia Saiontz-MartinezData Analytics, Evidera Inc., Wilmington, North Carolina, USA.
Zhenxiang ZhaoNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Fatima Cody StanfordMassachusetts General Hospital, MGH Weight Center, Department of Medicine-Division of Endocrinology-Neuroendocrine, Department of Pediatrics-Division of Endocrinology, Nutrition Obesity Research Center at Harvard (NORCH), Boston, Massachusetts, USA.

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
NIDDK NIH HHS P30 DK040561Novo Nordisk Inc., Plainsboro, NJ
6 · The paper itself

Abstract

To understand the prevalence, incidence and sequence of obesity-related comorbidities (ORCs) among people with obesity compared with those with a normal body mass index (BMI). People with obesity (BMI ≥30 kg/m

Indexed as

ObesityAdultAgedBody Mass IndexCohort StudiesComorbidityDyslipidemiasFemaleHumansHypertensionIncidenceMaleMiddle AgedPrevalenceTime FactorsUnited Statesbody mass indexevidence‐based practiceobesity

Identifiers

PMID40464112
PMCPMC12401642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.